Silicon Laboratories Inc. (NASDAQ:SLAB) Shares Sold by Emerald Advisers LLC

Emerald Advisers LLC decreased its holdings in shares of Silicon Laboratories Inc. (NASDAQ:SLAB) by 48.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 5,296 shares of the semiconductor company’s stock after selling 4,891 shares during the quarter. Emerald Advisers LLC’s holdings in Silicon Laboratories were worth $658,000 at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of the company. Jones Financial Companies Lllp boosted its position in Silicon Laboratories by 44.5% during the 4th quarter. Jones Financial Companies Lllp now owns 224 shares of the semiconductor company’s stock worth $28,000 after acquiring an additional 69 shares during the period. Advisors Asset Management Inc. lifted its holdings in Silicon Laboratories by 159.4% in the third quarter. Advisors Asset Management Inc. now owns 275 shares of the semiconductor company’s stock worth $32,000 after purchasing an additional 169 shares during the period. Venturi Wealth Management LLC grew its position in Silicon Laboratories by 207.0% in the 4th quarter. Venturi Wealth Management LLC now owns 786 shares of the semiconductor company’s stock valued at $98,000 after buying an additional 530 shares in the last quarter. Asset Management One Co. Ltd. acquired a new position in Silicon Laboratories during the 4th quarter valued at about $117,000. Finally, KBC Group NV raised its position in shares of Silicon Laboratories by 42.1% during the 4th quarter. KBC Group NV now owns 1,279 shares of the semiconductor company’s stock worth $159,000 after buying an additional 379 shares in the last quarter.

Insider Buying and Selling at Silicon Laboratories

In related news, Director William G. Bock sold 2,000 shares of Silicon Laboratories stock in a transaction dated Wednesday, January 22nd. The stock was sold at an average price of $140.77, for a total value of $281,540.00. Following the sale, the director now owns 32,115 shares of the company’s stock, valued at approximately $4,520,828.55. The trade was a 5.86 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Navdeep S. Sooch sold 2,360 shares of Silicon Laboratories stock in a transaction dated Wednesday, February 5th. The shares were sold at an average price of $149.00, for a total value of $351,640.00. Following the completion of the sale, the director now directly owns 400,567 shares in the company, valued at approximately $59,684,483. This represents a 0.59 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 5,360 shares of company stock valued at $782,610 in the last 90 days. 1.72% of the stock is currently owned by company insiders.

Silicon Laboratories Stock Performance

NASDAQ:SLAB opened at $123.57 on Monday. The stock’s fifty day moving average price is $138.03 and its two-hundred day moving average price is $123.28. Silicon Laboratories Inc. has a 52-week low of $94.00 and a 52-week high of $160.00. The company has a market cap of $4.01 billion, a price-to-earnings ratio of -20.80 and a beta of 1.15.

Silicon Laboratories (NASDAQ:SLAB) last posted its quarterly earnings results on Tuesday, February 4th. The semiconductor company reported ($0.11) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.11). The business had revenue of $166.25 million for the quarter, compared to analyst estimates of $166.09 million. Silicon Laboratories had a negative return on equity of 10.46% and a negative net margin of 32.69%. The firm’s revenue was up 91.4% on a year-over-year basis. During the same period last year, the company earned ($1.19) EPS. On average, equities analysts predict that Silicon Laboratories Inc. will post -0.97 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

SLAB has been the topic of a number of research reports. Benchmark reissued a “buy” rating and issued a $160.00 price objective on shares of Silicon Laboratories in a research note on Wednesday, March 12th. KeyCorp boosted their price objective on Silicon Laboratories from $115.00 to $160.00 and gave the stock an “overweight” rating in a research note on Wednesday, January 22nd. Needham & Company LLC reissued a “buy” rating and issued a $150.00 price objective on shares of Silicon Laboratories in a research note on Wednesday, March 12th. Stifel Nicolaus boosted their price objective on Silicon Laboratories from $135.00 to $145.00 and gave the stock a “buy” rating in a research note on Monday, January 6th. Finally, Barclays lifted their target price on Silicon Laboratories from $75.00 to $120.00 and gave the stock an “equal weight” rating in a report on Friday, January 17th. Six equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $136.20.

Silicon Laboratories Company Profile

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.